Core Points - The eleventh batch of national drug centralized procurement has officially started, with new reporting rules introduced to enhance the diversity of drug procurement options for medical institutions [1][2] - Medical institutions are required to report their procurement needs from August 6 to August 25, with participation mandated for all public and military medical institutions [1] - The new reporting rules allow institutions to report by brand name or by drug variety, providing flexibility in meeting clinical needs [1][2] Group 1: Reporting Rules - The new procurement rules include an option for institutions to report by brand name, addressing the diverse medication needs of the public [1] - Institutions can choose to report either by drug variety or by specific brand, with no limit on the number of brands that can be reported [1][2] - Institutions must ensure that total reported quantities are not less than 80% of the average procurement volume for 2023 and 2024 [2] Group 2: Demand Assessment - Institutions are encouraged to consider clinical demand changes and report sufficient quantities, especially for drugs with increasing usage trends [2][3] - For drugs with uncertain demand, such as those related to seasonal diseases, institutions can adjust their reported quantities based on actual needs [3] - Institutions can also reduce reported quantities for drugs with expected lower usage due to departmental adjustments or temporary needs [3] Group 3: Procurement Flexibility - Institutions are allowed to procure non-selected drugs if the selected drugs do not meet clinical needs, with a requirement to fulfill 60% to 80% of the procurement agreement with selected drugs [3] - The centralized procurement policy encourages the use of selected drugs while allowing flexibility for additional procurement based on actual demand [3][4] - Since 2018, a total of 435 drugs have been procured through 10 batches of national centralized procurement, improving drug accessibility and quality for the public [3]
第十一批国家组织药品集采报量启动——优化规则满足群众多元用药需求
Jing Ji Ri Bao·2025-08-18 00:05